Download Your Complimentary Copy of the Agenda
The 7th RAS-Targeted Drug Development Summit is your unique forum to learn and network with the brightest minds revolutionising the RAS-targeting industry.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Hear What Our Expert Speakers Had to Say
A wonderful opportunity to participate in a comprehensive RAS focused conference with diverse coverage of multiple approaches (SMIs & biologics) that target RAS with the end game to expeditiously deliver novel therapies to patients.
Michael Niedbala, Executive Director, Early Oncology Projects, AstraZenecaFirst
This summit is one of the few and best forums focusing on RAS-targeting drugs for industry leaders and researchers. It is extremely helpful as several classes of KRAS inhibitors and degraders are in clinical development.
Huaixiang Hao,Vice President, Head, Research, PAQ Therapeutics